Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss - PubMed (original) (raw)
Comparative Study
. 2004 Jun;39(6):1647-54.
doi: 10.1002/hep.20251.
Affiliations
- PMID: 15185306
- DOI: 10.1002/hep.20251
Comparative Study
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
John B Dixon et al. Hepatology. 2004 Jun.
Abstract
The effect of significant weight loss on nonalcoholic fatty liver disease remains unclear. In this case series of 36 selected obese patients, we examined the effect of weight loss on nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis (NASH) and hepatic fibrosis. These 36 patients (11 males, 25 females) had paired liver biopsies, the first at the time of laparoscopic adjustable gastric band placement and the second after weight loss. Second biopsies were obtained from two groups: those requiring a subsequent laparoscopic procedure (n = 19) and those with index biopsy score of 2 or greater for zone 3-centric hepatic fibrosis (n = 17). All biopsies were scored, blinded to the patient's identity and clinical condition, for individual histological features and for NASH stage and grade. Initial biopsies demonstrated NASH in 23 patients and steatosis in 12 patients. Repeat biopsies were taken at 25.6 +/- 10 months (range, 9-51 months) after band placement. Mean weight loss was 34.0 +/- 17 kg, and percentage of excess weight loss was 52 +/- 17%. There were major improvements in lobular steatosis, necroinflammatory changes, and fibrosis at the second biopsy (P <.001 for all). Portal abnormalities remained unchanged. Only four of the repeat biopsies fulfilled the criteria for NASH. There were 18 patients with an initial fibrosis score of 2 or more compared with 3 patients at follow-up (P <.001). Those with the metabolic syndrome (n = 23) had more extensive changes before surgery and greater improvement with weight loss. In conclusion, weight loss after surgery provides major improvement or resolution of obesity and metabolic syndrome-associated abnormal liver histological features in severely obese subjects.
Similar articles
- Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB, Bhathal PS, O'Brien PE. Dixon JB, et al. Obes Surg. 2006 Oct;16(10):1278-86. doi: 10.1381/096089206778663805. Obes Surg. 2006. PMID: 17059735 - Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Liew PL, et al. Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392. Obes Surg. 2006. PMID: 17217634 - Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
Weiner RA. Weiner RA. Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460923 - Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
Tilg H, Moschen A. Tilg H, et al. Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Minerva Gastroenterol Dietol. 2010. PMID: 20485253 Review. - Non-alcoholic steatohepatitis in children.
Nanda K. Nanda K. Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
Cited by
- Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.
Hoshida Y, Fuchs BC, Tanabe KK. Hoshida Y, et al. Curr Cancer Drug Targets. 2012 Nov 1;12(9):1129-59. Curr Cancer Drug Targets. 2012. PMID: 22873223 Free PMC article. Review. - De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
Eissing L, Scherer T, Tödter K, Knippschild U, Greve JW, Buurman WA, Pinnschmidt HO, Rensen SS, Wolf AM, Bartelt A, Heeren J, Buettner C, Scheja L. Eissing L, et al. Nat Commun. 2013;4:1528. doi: 10.1038/ncomms2537. Nat Commun. 2013. PMID: 23443556 Free PMC article. - Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
Guha IN, Parkes J, Roderick PR, Harris S, Rosenberg WM. Guha IN, et al. Gut. 2006 Nov;55(11):1650-60. doi: 10.1136/gut.2006.091454. Gut. 2006. PMID: 17047111 Free PMC article. Review. - Non-Alcoholic Fatty Liver Disease, an Overview.
Nd AM. Nd AM. Integr Med (Encinitas). 2019 Apr;18(2):42-49. Integr Med (Encinitas). 2019. PMID: 31341444 Free PMC article. Review. - Liver: Does bariatric surgery reduce the severity of NAFLD?
Cotrim HP, Daltro C. Cotrim HP, et al. Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):11-3. doi: 10.1038/nrgastro.2009.215. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20051969 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical